{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:29:08Z","timestamp":1788974948982,"version":"build-2803163510"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973837, 81704067, 81430097"],"award-info":[{"award-number":["81973837, 81704067, 81430097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>With socioeconomic advances and improved living standards, metabolic syndrome has increasingly come into the attention. In recent decades, a growing number of studies have shown that the gut microbiome and its metabolites are closely related to the occurrence and development of many metabolic diseases, and play an important role that cannot be ignored, for instance, obesity, type 2 diabetes (T2DM), non-alcoholic fatty liver disease (NAFLD), cardiovascular disease and others. The correlation between gut microbiota and metabolic disorder has been widely recognized. Metabolic disorder could cause imbalance in gut microbiota, and disturbance of gut microbiota could aggravate metabolic disorder as well. Berberine (BBR), as a natural ingredient, plays an important role in the treatment of metabolic disorder. Studies have shown that BBR can alleviate the pathological conditions of metabolic disorders, and the mechanism is related to the regulation of gut microbiota: gut microbiota could regulate the absorption and utilization of berberine in the body; meanwhile, the structure and function of gut microbiota also changed after intervention by berberine. Therefore, we summarize relevant mechanism research, including the expressions of nitroreductases-producing bacteria to promote the absorption and utilization of berberine, strengthening intestinal barrier function, ameliorating inflammation regulating bile acid signal pathway and axis of bacteria-gut-brain. The aim of our study is to clarify the therapeutic characteristics of berberine further and provide the theoretical basis for the regulation of metabolic disorder from the perspective of gut microbiota.<\/jats:p>","DOI":"10.3389\/fcimb.2022.854885","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T03:11:52Z","timestamp":1661397112000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["The mechanism of berberine alleviating metabolic disorder based on gut microbiome"],"prefix":"10.3389","volume":"12","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1079\/BJN20031088","article-title":"Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men","volume":"91","author":"Archer","year":"2004","journal-title":"Br. J. Nutr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"36133","DOI":"10.1039\/c8ra06413j","article-title":"Inhibition of biofilm formation and quorum sensing mediated phenotypes by berberine in Pseudomonas aeruginosa and Salmonella typhimurium","volume":"8","author":"Aswathanarayan","year":"2018","journal-title":"RSC Adv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jep.2016.10.043","article-title":"Response of gut microbiota and inflammatory status to bitter melon (Momordica charantia L.) in high fat diet induced obese rats","volume":"194","author":"Bai","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabetes Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12944-016-0278-4","article-title":"The role of Gut Microbiota in the development of obesity and Diabetes","volume":"15","author":"Baothman","year":"2016","journal-title":"Lipids Health Dis."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02335-19","article-title":"Live and Diet by Your Gut Microbiota","volume":"10","author":"Bassis","year":"2019","journal-title":"mBio."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/jmf.2019.0088","article-title":"Berberine and Dyslipidemia: Different Applications and Biopharmaceutical Formulations Without Statin-Like Molecules-A Meta-Analysis","volume":"23","author":"Bertuccioli","year":"2020","journal-title":"J. Med. Food."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.aambs.2015.02.001","article-title":"Microbiota regulation of the Mammalian gut-brain axis","volume":"91","author":"Burokas","year":"2015","journal-title":"Adv. Appl. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.2174\/0929867323666160411143314","article-title":"Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders","volume":"23","author":"Caliceti","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1139\/h06-072","article-title":"Getting to the bottom of feeding behaviour: who's on top","volume":"32","author":"Cameron","year":"2007","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","article-title":"Gut microbial metabolites in obesity, NAFLD and T2DM. Nat","volume":"15","author":"Canfora","year":"2019","journal-title":"Rev. Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41574-018-0143-9","article-title":"Microbiota and metabolites in metabolic diseases","volume":"15","author":"Cani","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.coph.2009.06.016","article-title":"Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota","volume":"9","author":"Cani","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.coph.2013.09.008","article-title":"Gut microbiota, enteroendocrine functions and metabolism","volume":"13","author":"Cani","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.578943","article-title":"Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice","volume":"11","author":"Cao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.etap.2018.09.007","article-title":"9-O-benzoyl-substituted berberine exerts a triglyceride-lowering effect through AMPK signaling pathway in human hepatoma HepG2 cells","volume":"64","author":"Cao","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","article-title":"Berberine and Its Role in Chronic Disease","volume":"928","author":"Cicero","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24010103","article-title":"Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability","volume":"24","author":"Cui","year":"2018","journal-title":"Molecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","article-title":"SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond","volume":"43","author":"Debose-Boyd","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5009\/gnl.2012.6.1.10","article-title":"Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity","volume":"6","author":"De Silva","year":"2012","journal-title":"Gut Liver."},{"key":"B26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","article-title":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits","volume":"156","author":"De Vadder","year":"2014","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00052-19","article-title":"Clostridium scindens ATCC 35704: Integration of Nutritional Requirements, the Complete Genome Sequence, and Global Transcriptional Responses to Bile Acids","volume":"85","author":"Devendran","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"B28","article-title":"Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data","author":"Direct","year":"2002","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111595","article-title":"Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion","volume":"139","author":"Dong","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1476-5381.2011.01687.x","article-title":"The structure and function of the glucagon-like peptide-1 receptor and its ligands","volume":"166","author":"Donnelly","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"13573","DOI":"10.1111\/jcmm.16049","article-title":"Anti-inflammatory and immune-modulatory impacts of berberine on activation of autoreactive T cells in autoimmune inflammation","volume":"24","author":"Ehteshamfar","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.2337\/db11-0227","article-title":"Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice","volume":"60","author":"Everard","year":"2011","journal-title":"Diabetes"},{"key":"B34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/ismej.2012.153","article-title":"An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice","volume":"7","author":"Fei","year":"2013","journal-title":"ISME J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"11278","DOI":"10.7150\/thno.47289","article-title":"Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs","volume":"10","author":"Feng","year":"2020","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/srep12155","article-title":"Transforming berberine into its intestine-absorbable form by the gut microbiota","volume":"5","author":"Feng","year":"2015","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00214","article-title":"Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration","volume":"9","author":"Feng","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"16079","DOI":"10.3748\/wjg.v20.i43.16079","article-title":"Gut microbiota and metabolic syndrome","volume":"20","author":"Festi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"16649","DOI":"10.3748\/wjg.v20.i44.16649","article-title":"Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion","volume":"20","author":"Finelli","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/1566524011009060579","article-title":"Counter-regulatory role of bile acid activated receptors in immunity and inflammation","volume":"10","author":"Fiorucci","year":"2010","journal-title":"Curr. Mol. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cell.2018.07.038","article-title":"Microbiome: Focus on Causation and Mechanism","volume":"174","author":"Fischbach","year":"2018","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00253-007-1180-9","article-title":"Transcriptional profile induced by furazolidone treatment of Shigella flexneri","volume":"77","author":"Fu","year":"2007","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1039\/d1fo04003k","article-title":"Responses of human gut microbiota abundance and amino acid metabolism in vitro to berberine","volume":"13","author":"Fu","year":"2022","journal-title":"Food Funct."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1813086","article-title":"New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the \"Bacteria-Mucosal Immunity-Inflammation-Diabetes\" Axis","volume":"2017","author":"Gao","year":"2017","journal-title":"J. Immunol. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/19490976.2018.1465157","article-title":"The human gut microbiota: Metabolism and perspective in obesity","volume":"9","author":"Gomes","year":"2018","journal-title":"Gut Microbes"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00042","article-title":"Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats","volume":"8","author":"Gong","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00042","article-title":"Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats","volume":"8","author":"Gong","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41574-018-0014-4","article-title":"Exercise affects gut microbiota and bone","volume":"14","author":"Greenhill","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1039\/c4mb00500g","article-title":"A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine","volume":"11","author":"Gu","year":"2015","journal-title":"Mol. Biosyst."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12120769","article-title":"Mycotoxin and Gut Microbiota Interactions","volume":"12","author":"Guerre","year":"2020","journal-title":"Toxins (Basel)."},{"key":"B52","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12906-016-1367-7","article-title":"Dose-response effect of berberine on bile acid profile and gut microbiota in mice","volume":"16","author":"Guo","year":"2016","journal-title":"BMC Complement Altern. Med."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: A hidden therapeutic link","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182467","article-title":"In vivo therapeutic effect of combination treatment with metformin and Scutellaria baicalensis on maintaining bile acid homeostasis","volume":"12","author":"Han","year":"2017","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"E1409","DOI":"10.1210\/jc.2011-0647","article-title":"2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans","volume":"96","author":"Hansen","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6020032","article-title":"The Role of Gut Microbiota in Obesity and Type 2 and Type 1 Diabetes Mellitus: New Insights into \"Old\" Diseases","volume":"6","author":"Harsch","year":"2018","journal-title":"Med. Sci. (Basel)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1002\/ptr.6984","article-title":"A review on pain-relieving activity of berberine","volume":"35","author":"Hashemzaei","year":"2021","journal-title":"Phytother. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.bbadis.2016.06.006","article-title":"Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways","volume":"1862","author":"He","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.bbadis.2016.06.006","article-title":"Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways","volume":"1862","author":"He","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1126\/science.336.6086.1248","article-title":"My microbiome and me","volume":"336","author":"Hvistendahl","year":"2012","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: between good and evil","volume":"65","author":"Ianiro","year":"2016","journal-title":"Gut."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110137","article-title":"The effect of Berberine on weight loss in order to prevent obesity: A systematic review","volume":"127","author":"Ilyas","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ptr.5693","article-title":"Berberis Vulgaris and Berberine: An Update Review","volume":"30","author":"Imenshahidi","year":"2016","journal-title":"Phytother. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.envpol.2016.11.045","article-title":"Effects of environmental pollutants on gut microbiota","volume":"222","author":"Jin","year":"2017","journal-title":"Environ. Pollut."},{"key":"B66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1753425908095130","article-title":"Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients","volume":"14","author":"Kallio","year":"2008","journal-title":"Innate Immun."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1348-0421.1982.tb00249.x","article-title":"Biotransformation of 1-nitropyrene in intestinal anaerobic bacteria","volume":"26","author":"Kinouchi","year":"1982","journal-title":"Microbiol. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ptr.2968","article-title":"Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders","volume":"24","author":"Kulkarni","year":"2010","journal-title":"Phytother. Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2003.09.002","article-title":"The anti-inflammatory potential of berberine in vitro and in vivo","volume":"203","author":"Kuo","year":"2004","journal-title":"Cancer Lett."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122862","article-title":"Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration","volume":"11","author":"Leeming","year":"2019","journal-title":"Nutrients."},{"key":"B74","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","article-title":"Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-\/- Mice","volume":"133","author":"Li","year":"2016","journal-title":"Circulation."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00009","article-title":"A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1055\/s-0043-125066","article-title":"Berberine Modulates Gut Microbiota and Reduces Insulin Resistance via the TLR4 Signaling Pathway","volume":"126","author":"Liu","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"B79","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.fitote.2016.02.001","article-title":"Research progress on berberine with a special focus on its oral bioavailability","volume":"109","author":"Liu","year":"2016","journal-title":"Fitoterapia."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/ptr.6588","article-title":"Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice","volume":"34","author":"Li","year":"2020","journal-title":"Phytother. Res."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110953","article-title":"Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db\/db mice","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2174\/1871527311211080013","article-title":"The protective effects of jatrorrhizine on beta-amyloid (25-35)-induced neurotoxicity in rat cortical neurons","volume":"11","author":"Luo","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B83","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1677\/JOE-08-0419","article-title":"Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats","volume":"200","author":"Lu","year":"2009","journal-title":"J. Endocrinol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00782","article-title":"The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1530\/JME-17-0014","article-title":"Berberine reduced blood pressure and improved vasodilation in diabetic rats","volume":"59","author":"Ma","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.pan.2019.01.021","article-title":"). Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes","volume":"19","author":"Mandaliya","year":"2019","journal-title":"Pancreatology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"17358","DOI":"10.1038\/s41598-020-73661-5","article-title":"Exposure to the natural alkaloid Berberine affects cardiovascular system morphogenesis and functionality during zebrafish development","volume":"10","author":"Martini","year":"2020","journal-title":"Sci. Rep."},{"key":"B88","doi-asserted-by":"crossref","DOI":"10.1038\/ismej.2011.139","article-title":"An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea","author":"Mcdonald","year":"2012","journal-title":"ISME J"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/nu9121348","article-title":"Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance","volume":"9","author":"Mcnabney","year":"2017","journal-title":"Nutrients."},{"key":"B90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/er.2017-00192","article-title":"Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans","volume":"39","author":"Meijnikman","year":"2018","journal-title":"Endocr. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/jrms.JRMS_1078_17","article-title":"Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients","volume":"23","author":"Memon","year":"2018","journal-title":"J. Res. Med. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13073-021-00942-7","article-title":"Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study","volume":"13","author":"Ming","year":"2021","journal-title":"Genome Med."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051436","article-title":"Prebiotic Effect of Berberine and Curcumin Is Associated with the Improvement of Obesity in Mice","volume":"13","author":"Neyrinck","year":"2021","journal-title":"Nutrients."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners","volume":"69","author":"Paone","year":"2020","journal-title":"Gut."},{"key":"B95","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00498","article-title":"ditorial: Gastrointestinal Hormones","volume":"10","author":"Paternoster","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B97","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/imm.13028","article-title":"Interleukin-17\/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model","volume":"156","author":"Perez","year":"2019","journal-title":"Immunology."},{"key":"B98","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.fitote.2010.07.012","article-title":"The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals","volume":"82","author":"Possemiers","year":"2011","journal-title":"Fitoterapia."},{"key":"B100","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2337\/dc10-1676","article-title":"Endotoxemia is associated with an increased risk of incident diabetes","volume":"34","author":"Pussinen","year":"2011","journal-title":"Diabetes Care"},{"key":"B101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature."},{"key":"B102","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.572912","article-title":"Antibiotics as Major Disruptors of Gut Microbiota","volume":"10","author":"Ramirez","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3920\/BM2014.0104","article-title":"Gut microbiota composition correlates with changes in body fat content due to weight loss","volume":"6","author":"Remely","year":"2015","journal-title":"Benef. Microbes"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"key":"B106","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/19490976.2019.1618173","article-title":"The 'in vivo lifestyle' of bile acid 7alpha-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice","volume":"11","author":"Ridlon","year":"2020","journal-title":"Gut Microbes"},{"key":"B107","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MCO.0b013e328302c9b0","article-title":"Gut-brain axis","volume":"11","author":"Romijn","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B108","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1128\/JCM.42.9.4127-4129.2004","article-title":"Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State","volume":"42","author":"Schapiro","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front. Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B111","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/00325481.2018.1410054","article-title":"Increased prevalence of depression and anxiety among subjects with metabolic syndrome and known type 2 diabetes mellitus - a population-based study","volume":"130","author":"Shinkov","year":"2018","journal-title":"Postgrad. Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"15641","DOI":"10.1038\/s41598-019-52253-y","article-title":"Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice","volume":"9","author":"Singh","year":"2019","journal-title":"Sci. Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11892-018-1057-6","article-title":"Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence","volume":"18","author":"Sircana","year":"2018","journal-title":"Curr. Diabetes Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.07.009","article-title":"The gastrointestinal microbiota as a site for the biotransformation of drugs","volume":"363","author":"Sousa","year":"2008","journal-title":"Int. J. Pharm."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8111715","article-title":"The Influence of Probiotics on the Firmicutes\/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease","volume":"8","author":"Stojanov","year":"2020","journal-title":"Microorganisms"},{"key":"B116","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000449507","article-title":"Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats","volume":"9","author":"Sun","year":"2016","journal-title":"Obes. Facts."},{"key":"B117","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/mol.116.106617","article-title":"Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway","volume":"91","author":"Sun","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"557","DOI":"10.22038\/IJBMS.2017.8682","article-title":"A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome","volume":"20","author":"Tabeshpour","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.numecd.2012.09.002","article-title":"The role of gut microbiota in human obesity: recent findings and future perspectives","volume":"23","author":"Tagliabue","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e77969","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PloS One"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0214-1","article-title":"Is serum Interleukin-17 associated with early atherosclerosis in obese patients","volume":"12","author":"Tarantino","year":"2014","journal-title":"J. Transl. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aar3318","article-title":"Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection","volume":"359","author":"Thaiss","year":"2018","journal-title":"Science"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut."},{"key":"B124","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2015.07.007","article-title":"Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome","volume":"22","author":"Ussar","year":"2015","journal-title":"Cell Metab."},{"key":"B125","doi-asserted-by":"publisher","first-page":"E334","DOI":"10.1152\/ajpendo.00107.2017","article-title":"Reduced obesity, diabetes, and steatosis upon cinnamon and grape pomace are associated with changes in gut microbiota and markers of gut barrier","volume":"314","author":"Van Hul","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B126","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/0004563212473450","article-title":"Higher circulating bile acid concentrations in obese patients with type 2 diabetes","volume":"50","author":"Vincent","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.609134","article-title":"Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B129","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.metabol.2017.02.003","article-title":"Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism","volume":"70","author":"Wang","year":"2017","journal-title":"Metabolism"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.7150\/thno.18290","article-title":"Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics."},{"key":"B131","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2174\/1871530320666200910105612","article-title":"Berberine as a Potential Multi-Target Agent for Metabolic Diseases: A Review of Investigations for Berberine","volume":"21","author":"Wang","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets."},{"key":"B132","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10620-006-9320-0","article-title":"Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1beta","volume":"52","author":"Weglarz","year":"2007","journal-title":"Dig Dis. Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1038\/s41598-018-22094-2","article-title":"Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota","volume":"8","author":"Wei","year":"2018","journal-title":"Sci. Rep."},{"key":"B134","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12866-020-02020-1","article-title":"Berberine alters gut microbial function through modulation of bile acids","volume":"21","author":"Wolf","year":"2021","journal-title":"BMC Microbiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s13238-020-00814-7","article-title":"The role of the gut microbiome and its metabolites in metabolic diseases","volume":"12","author":"Wu","year":"2021","journal-title":"Protein Cell."},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00223","article-title":"Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-\/- Mice","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"9910","DOI":"10.1002\/jcb.27312","article-title":"Bidirectional regulation of adenosine 5'-monophosphate-activated protein kinase activity by berberine and metformin in response to changes in ambient glucose concentration","volume":"119","author":"Xiao","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/med.21431","article-title":"Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota","volume":"37","author":"Xu","year":"2017","journal-title":"Med. Res. Rev."},{"key":"B139","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.gpb.2019.09.007","article-title":"Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine","volume":"18","author":"Xu","year":"2020","journal-title":"Genomics Proteomics Bioinf."},{"key":"B140","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.gpb.2019.09.007","article-title":"Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine","volume":"18","author":"Xu","year":"2020","journal-title":"Genomics Proteomics Bioinf."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.3892\/mmr.2017.6321","article-title":"Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels","volume":"15","author":"Xu","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110984","article-title":"Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence","volume":"133","author":"Xu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709629","article-title":"Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B144","author":"Yang","year":"2021"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease","volume":"10","author":"Yan","year":"2015","journal-title":"PloS One"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e12524","DOI":"10.1111\/jpi.12524","article-title":"Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice","volume":"65","author":"Yin","year":"2018","journal-title":"J. Pineal Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism."},{"key":"B148","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.apsb.2012.06.003","article-title":"Effects and mechanisms of berberine in diabetes treatment","volume":"2","author":"Yin","year":"2012","journal-title":"Acta Pharm. Sin. B."},{"key":"B149","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2337\/db19-611-P","article-title":"611-P: Berberine Prevented High-Fat Diet-Induced Metabolic Disorders via Inhibition of Whole Lipid Metabolism","volume":"68","author":"Yu","year":"2019","journal-title":"Diabetes"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.bcp.2009.11.017","article-title":"Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies","volume":"79","author":"Yu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00538","article-title":"Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"B153","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s12020-018-1689-y","article-title":"Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3","volume":"62","author":"Zhang","year":"2018","journal-title":"Endocrine."},{"key":"B154","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.fct.2010.09.032","article-title":"Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides","volume":"49","author":"Zhang","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01461","article-title":"Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"Zhang","year":"2010","journal-title":"Metabolism."},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109131","article-title":"Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db\/db mice","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/srep14405","article-title":"Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e42529","DOI":"10.1371\/journal.pone.0042529","article-title":"Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats","volume":"7","author":"Zhang","year":"2012","journal-title":"PloS One"},{"key":"B160","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1875-5364(19)30101-3","article-title":"Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases","volume":"17","author":"Zhou","year":"2019","journal-title":"Chin. J. Nat. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.fitote.2015.06.005","article-title":"Coptisine attenuates obesity-related inflammation through LPS\/TLR-4-mediated signaling pathway in Syrian golden hamsters","volume":"105","author":"Zou","year":"2015","journal-title":"Fitoterapia."},{"key":"B162","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/aps.2016.125","article-title":"Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system","volume":"38","author":"Zou","year":"2017","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.854885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T03:11:59Z","timestamp":1661397119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.854885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":162,"alternative-id":["10.3389\/fcimb.2022.854885"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.854885","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"article-number":"854885"}}